Xiaojing Ma

12.2k citations
156 papers · 10.2k · 2 hit papers · h-index 50

Impact in

  • Immunology top 0.2%
    • Immune Cell Function and Interaction
    • Immune Response and Inflammation
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immune cells in cancer
    • Phagocytosis and Immune Regulation
  • Oncology top 1%
    • CAR-T cell therapy research
    • Cytokine Signaling Pathways and Interactions

Papers in

    • Immune Cell Function and Interaction 39
    • Immune Response and Inflammation 24
    • Immunotherapy and Immune Responses 17
    • Immune cells in cancer 14
    • T-cell and B-cell Immunology 14
    • Cytokine Signaling Pathways and Interactions 21

Xiaojing Ma

142 papers receiving 9.9k citations

Xiaojing Ma's Hit Papers

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo 2018 · 693 citations
6930+11+22Years since publication4008001.2k

Peers

Xiaojing Ma
Comparison fields: 5 of 134
  • Immunology 5.2k
  • Oncology 2.5k
  • Virology 334
  • Cancer Research 687
  • Parasitology 238
Replace Angel Francisco Lopez with:
Angel Francisco Lopez Australia
Xuexian O. Yang United States
Roza Nurieva United States
Deborah J. Lenschow United States
Dieter Kabelitz Germany
Michael Croft United States
Megan K. Levings Canada
Alejandro V. Villarino United States
Franck J. Barrat United States
Jason D. Fontenot United States
Xiaojing Ma relative to Angel Francisco Lopez Australia Angel Francisco Lopez's profile →
Citations per field
00.5×1.5×
Angel Francisco Lopez · 1×
Citations per year

Countries citing papers authored by Xiaojing Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Ma more than expected).

Fields of papers citing papers by Xiaojing Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Ma. The network helps show where Xiaojing Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaojing Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaojing Ma Line = papers co-authored together Xiaojing Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
Hit paper breakdown →
19931245
2
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Hit paper breakdown →
2018693
3 2009417
4 1994388
5 1998331
6 2002253
7 1995248
8 2004238
9 2018232
10 2015228
11 1999211
12 2007209
13 2005204
14 1997177
15 2000169
16 2009168
17 2007165
18 2003157
19 2005153
20 2005151

About Xiaojing Ma

Xiaojing Ma is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Epidemiology, having authored 156 papers that have together received 10.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (39 papers), Immune Response and Inflammation (24 papers), Cytokine Signaling Pathways and Interactions (21 papers), Immunotherapy and Immune Responses (17 papers), NF-κB Signaling Pathways (15 papers), Immune cells in cancer (14 papers), T-cell and B-cell Immunology (14 papers) and Ubiquitin and proteasome pathways (10 papers). The work is most often cited by research in Immunology (5.2k citations), Oncology (2.5k citations), Virology (334 citations), Cancer Research (687 citations) and Parasitology (238 citations). Xiaojing Ma has collaborated with scholars based in United States, China and Qatar. Frequent co-authors include Giorgio Trinchieri, Miguel Aste-Amézaga, Annalisa D’Andrea, Marek Z. Kubin, Nicholas M. Valiante, Jianguo Liu, Keith B. Elkon, Shanjin Cao, Xiuqin Guan and Jianguo Liu. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, The Journal of Experimental Medicine, Annals of the New York Academy of Sciences and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact